Stockholders’ Equity - Schedule of Range Exercise Prices of Warrants Outstanding and Exercisable (Details) - Warrant [Member] |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| Schedule of Range Exercise Prices of Warrants Outstanding and Exercisable [Line Items] | |
| Warrants Outstanding, Range of Exercise Prices (in Dollars per share) | $ 0.06 |
| Warrants Outstanding, Shares Outstanding | shares | 1,435,000 |
| Warrants Outstanding, Weighted Avg. Remaining Contractual Life in Years | 2 years 10 months 24 days |
| Warrants Outstanding, Weighted Avg. Exercise Price (in Dollars per share) | $ 0.06 |
| Warrants Exercisable, Shares Exercisable | shares | 1,435,000 |
| Warrants Exercisable, Weighted Avg. Exercise Price | $ 0.06 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for outstanding stock option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|